Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia
Author:
Affiliation:
1. Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
Funder
Italiana per la Ricerca sul Cancro
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728214.2021.1956462
Reference137 articles.
1. Myths and Lessons from the Adult/Pediatric Interface in Acute Lymphoblastic Leukemia
2. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
3. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
4. Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States
5. Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia;Frontiers in Oncology;2023-01-10
2. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care;Medicina;2022-10-02
3. Modern Management Options for Ph+ ALL;Cancers;2022-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3